These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29944958)

  • 21. Antimicrobial peptidase lysostaphin at subinhibitory concentrations modulates staphylococcal adherence, biofilm formation, and toxin production.
    Yue Y; Chen K; Sun C; Ahmed S; Ojha SC
    BMC Microbiol; 2023 Oct; 23(1):311. PubMed ID: 37884887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unprotonated Short-Chain Alkylamines Inhibit Staphylolytic Activity of Lysostaphin in a Wall Teichoic Acid-Dependent Manner.
    Wu X; Kwon SJ; Kim D; Zha J; Mora-Pale M; Dordick JS
    Appl Environ Microbiol; 2018 Jul; 84(14):. PubMed ID: 29728390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1.
    Sugai M; Fujiwara T; Akiyama T; Ohara M; Komatsuzawa H; Inoue S; Suginaka H
    J Bacteriol; 1997 Feb; 179(4):1193-202. PubMed ID: 9023202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced production of recombinant
    Duman ZE; Ünlü A; Çakar MM; Ünal H; Binay B
    Prep Biochem Biotechnol; 2019; 49(5):521-528. PubMed ID: 31017522
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
    Kusuma CM; Kokai-Kun JF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and structural characterization of LytU, a unique peptidoglycan endopeptidase from the lysostaphin family.
    Raulinaitis V; Tossavainen H; Aitio O; Juuti JT; Hiramatsu K; Kontinen V; Permi P
    Sci Rep; 2017 Jul; 7(1):6020. PubMed ID: 28729697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient production of Staphylococcus simulans lysostaphin in a benchtop bioreactor by recombinant Escherichia coli.
    Szweda P; Gorczyca G; Filipkowski P; Zalewska M; Milewski S
    Prep Biochem Biotechnol; 2014; 44(4):370-81. PubMed ID: 24320237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein.
    Gargis SR; Heath HE; LeBlanc PA; Dekker L; Simmonds RS; Sloan GL
    Appl Environ Microbiol; 2010 Oct; 76(20):6944-6. PubMed ID: 20729317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus.
    Baba T; Schneewind O
    EMBO J; 1996 Sep; 15(18):4789-97. PubMed ID: 8890152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus.
    Thumm G; Götz F
    Mol Microbiol; 1997 Mar; 23(6):1251-65. PubMed ID: 9106216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus.
    Robinson JM; Hardman JK; Sloan GL
    J Bacteriol; 1979 Mar; 137(3):1158-64. PubMed ID: 438117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent.
    Osipovitch DC; Griswold KE
    FEMS Microbiol Lett; 2015 Jan; 362(2):1-7. PubMed ID: 25670705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of NaCl and pH on lysostaphin catalytic activity, cell binding, and bacteriolytic activity.
    Konstantinova S; Grishin A; Lyashchuk A; Vasina I; Karyagina A; Lunin V
    Appl Microbiol Biotechnol; 2022 Oct; 106(19-20):6519-6534. PubMed ID: 36112205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysostaphin: an antistaphylococcal agent.
    Kumar JK
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity.
    Osipovitch DC; Therrien S; Griswold KE
    Appl Microbiol Biotechnol; 2015 Aug; 99(15):6315-26. PubMed ID: 25690309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysostaphin: Engineering and Potentiation toward Better Applications.
    Zha J; Li J; Su Z; Akimbekov N; Wu X
    J Agric Food Chem; 2022 Sep; 70(37):11441-11457. PubMed ID: 36082619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of Lysostaphin by Nonproprietary Method Utilizing a Promoter from Toxin-Antitoxin System.
    Mądry A; Jendroszek A; Dubin G; Wladyka B
    Mol Biotechnol; 2019 Oct; 61(10):774-782. PubMed ID: 31446565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.
    Koehl JL; Muthaiyan A; Jayaswal RK; Ehlert K; Labischinski H; Wilkinson BJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3749-57. PubMed ID: 15388430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of Lif, the lysostaphin immunity factor, on acceptors of surface proteins and cell wall sorting efficiency in Staphylococcus carnosus.
    Strauss A; Thumm G; Götz F
    J Bacteriol; 1998 Sep; 180(18):4960-2. PubMed ID: 9733703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-site recognition of Staphylococcus aureus peptidoglycan by lysostaphin SH3b.
    Gonzalez-Delgado LS; Walters-Morgan H; Salamaga B; Robertson AJ; Hounslow AM; Jagielska E; Sabała I; Williamson MP; Lovering AL; Mesnage S
    Nat Chem Biol; 2020 Jan; 16(1):24-30. PubMed ID: 31686030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.